secwatch.observer — SEC 8-K summary
======================================

Issuer:     TITAN PHARMACEUTICALS INC (—)
CIK:        0000910267
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001829126-24-000082
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Titan Pharmaceuticals effects 1-for-20 reverse stock split; CUSIP changes to 888314705
--------------------------------------------------------------------------------

- Reverse split at 1-for-20 ratio effective January 8, 2024 at 5:00 p.m. ET.
- Stock continues trading on Nasdaq under symbol TTNP with new CUSIP 888314705.
- Approved by stockholders at special meeting on December 27, 2023 and by the Board on November 16, 2023.
- Continental Stock Transfer & Trust is exchange agent for the reverse split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910267/000182912624000082/0001829126-24-000082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910267/000182912624000082/titanpharma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-24-000082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer